XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue:        
Revenue $ 16,074 $ 594 $ 23,877 $ 2,610
Costs and expenses:        
Cost of product revenue 1,911 23 2,768 260
Research and development:        
Noncash compensation 5,664 2,328 7,247 4,223
Other research and development 22,458 24,546 36,744 70,693
Total research and development 28,122 26,874 43,991 74,916
Selling, general and administrative:        
Noncash compensation 6,877 (3,304) 12,117 (3,077)
Other selling, general and administrative 23,838 15,942 46,666 36,324
Total selling, general and administrative 30,715 12,638 58,783 33,247
Total costs and expenses 60,748 39,535 105,542 108,423
Operating loss (44,674) (38,941) (81,665) (105,813)
Other expense (income):        
Interest expense 3,627 3,017 6,471 5,681
Other income (691) (1,448) (1,295) (1,971)
Total other expense (income), net 2,936 1,569 5,176 3,710
Net loss $ (47,610) $ (40,510) $ (86,841) $ (109,523)
Basic net loss per common share (in dollars per share) $ (0.34) $ (0.30) $ (0.62) $ (0.81)
Diluted net loss per common share (in dollars per share) $ (0.34) $ (0.30) $ (0.62) $ (0.81)
Weighted-average shares used in computing basic net loss per common share (in shares) 141,503,738 134,779,904 140,911,295 134,591,250
Weighted-average shares used in computing diluted net loss per common share (in shares) 141,503,738 134,779,904 140,911,295 134,591,250
Product revenue, net [Member]        
Revenue:        
Revenue $ 16,036 $ 556 $ 23,801 $ 2,534
License revenue [Member]        
Revenue:        
Revenue $ 38 $ 38 $ 76 $ 76